Further investigations are needed to delineate the role of (a) cellular components (regulatory cells, natural killer cells, etc.)that include costimulatory versus coinhibitory molecules, (b) molecular components (CD28, CD86, CD80, etc.), and (c) cellular mechanisms involved in anti-tumor response. This evidence concerns the gene CD86 and neoplasm.